NARI vs. ICUI, TNDM, IRTC, NVCR, IART, PRCT, AXNX, LMAT, ATEC, and MDXG
Should you be buying Inari Medical stock or one of its competitors? The main competitors of Inari Medical include ICU Medical (ICUI), Tandem Diabetes Care (TNDM), iRhythm Technologies (IRTC), NovoCure (NVCR), Integra LifeSciences (IART), PROCEPT BioRobotics (PRCT), Axonics (AXNX), LeMaitre Vascular (LMAT), Alphatec (ATEC), and MiMedx Group (MDXG). These companies are all part of the "surgical & medical instruments" industry.
Inari Medical (NASDAQ:NARI) and ICU Medical (NASDAQ:ICUI) are both mid-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, community ranking, earnings and risk.
ICU Medical has a net margin of -2.63% compared to Inari Medical's net margin of -4.54%. ICU Medical's return on equity of 5.38% beat Inari Medical's return on equity.
Inari Medical has a beta of 0.93, meaning that its stock price is 7% less volatile than the S&P 500. Comparatively, ICU Medical has a beta of 0.72, meaning that its stock price is 28% less volatile than the S&P 500.
Inari Medical presently has a consensus target price of $65.71, suggesting a potential upside of 43.64%. ICU Medical has a consensus target price of $123.00, suggesting a potential upside of 18.28%. Given Inari Medical's higher probable upside, research analysts clearly believe Inari Medical is more favorable than ICU Medical.
Inari Medical has higher earnings, but lower revenue than ICU Medical. Inari Medical is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.
In the previous week, Inari Medical had 26 more articles in the media than ICU Medical. MarketBeat recorded 29 mentions for Inari Medical and 3 mentions for ICU Medical. ICU Medical's average media sentiment score of 1.13 beat Inari Medical's score of 0.17 indicating that ICU Medical is being referred to more favorably in the news media.
91.0% of Inari Medical shares are held by institutional investors. Comparatively, 96.1% of ICU Medical shares are held by institutional investors. 10.6% of Inari Medical shares are held by insiders. Comparatively, 6.7% of ICU Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
ICU Medical received 325 more outperform votes than Inari Medical when rated by MarketBeat users. However, 68.24% of users gave Inari Medical an outperform vote while only 64.48% of users gave ICU Medical an outperform vote.
Summary
Inari Medical and ICU Medical tied by winning 9 of the 18 factors compared between the two stocks.
Get Inari Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for NARI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NARI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Inari Medical Competitors List
Related Companies and Tools
